ArticleBlood advances2026

Minimal residual disease by high-throughput sequencing in standard risk-favorable pediatric B-lymphoblastic leukemia.

Carol Fries et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.